Spaltudaq Now Theraclone Sciences

Xconomy Seattle — 

Spaltudaq (SPAHL-too-dack), the Seattle-based maker of genetically engineered antibody drugs, has changed its name to Theraclone Sciences. Founder Johnny Stine, a member of the Snohomish tribe, gave the company its original name after a healing ceremony once performed by his ancestors in the Puget Sound region to make sure people don’t die before their time. The new name was chosen to “highlight our ability to clone and express clinically relevant, naturally fully human antibodies for clinical and commercial benefit,” said CEO David Fanning.